The UK government has announced the development of an AI-enabled early-warning system to identify emerging patient-safety concerns across the NHS in near real time. The initiative - framed within the 10-Year Health Plan and the wider shift from analogue to digital - aims to analyse routine datasets to detect patterns of risk earlier and enable the Care Quality Commission (CQC) to deploy targeted inspections more quickly where concerns arise.
As an early use case, a maternity outcomes signal system is expected to roll out across NHS trusts from November 2025. Using near real-time indicators such as rates of stillbirth, neonatal death and brain injury, the system is intended to escalate signals sooner, supporting faster local remediation and regulatory oversight in a service area that has seen significant public concern.
In this article we outline how the early-warning system will operate, what this means for healthcare providers and advise how organisations can start to prepare.
In broad terms, the approach envisages automated analysis of hospital data and reports submitted by healthcare staff - potentially drawing on the NHS Federated Data Platform - to flag unusual trends or clusters of incidents that may indicate a decline in care quality or safety. Where thresholds are met, the CQC would initiate earlier, more targeted inspections, complementing rather than replacing existing provider governance and incident management obligations.
The programme will need to balance timeliness with reliability: false positives risk unnecessary disruption, while false negatives risk missed opportunities to prevent harm. The quality, completeness and comparability of local datasets will therefore be central to performance.
For NHS organisations and independent providers interfacing with NHS pathways, the initiative places renewed emphasis on data quality as a patient-safety asset. Coding accuracy, latency, and clear lineage from clinical documentation to reported metrics will become increasingly important as signals may be triggered by small shifts in trend data. Providers should expect a stronger link between data quality assurance and inspection readiness.
Governance and oversight will also matter. Organisations will need defined processes for receiving external alerts, triaging them within clinical governance structures, documenting decisions and remedial actions, and evidencing learning and improvement. Given the public interest in maternity outcomes, boards should test whether existing escalation pathways, risk registers and quality improvement logs are sufficiently responsive for near real-time signals.
Finally, equity and transparency should be considered. Where AI-enabled tooling influences scrutiny or resource allocation, providers should be prepared to assess and explain potential differential impacts across patient groups and to engage openly with staff and patient representatives on how signals are generated and addressed.
Practical preparatory steps include:
The system is positioned as an adjunct to, not a substitute for, robust local clinical governance. Organisations that invest in data quality, clear escalation routes and transparent decision-making are likely to benefit most from earlier signal generation – identifying risks sooner and improving outcomes for patients and staff.
For support with data governance, AI assurance (including data protection impact assessments and bias testing frameworks) or CQC inspection readiness, please contact our data team and healthcare sector.
Employment and Data Protection webinar: the use of social media in recruitment and employment
We produce a range of insights and publications to help keep our clients up-to-date with legal and sector developments.
Sign up
